Readily Diagnostics develops speedy and accurate diagnostic tests for respiratory disorders, enabling faster therapy at the point of care.
Readily Diagnostics has raised $1.7M in total funding. The most recent round was Seed. The last funding was announced in October 2024.
Readily Diagnostics's investors include Almi Invest, Uppsala universitet Invest AB, Ulf Landegren.
Readily Diagnostics is headquartered in Uppsala, Sweden.
Readily Diagnostics develops speedy and accurate diagnostic tests for respiratory disorders, enabling faster therapy at the point of care.
Readily Diagnostics is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Readily Diagnostics — Funding & Investors." VCBacked, October 30, 2024, https://www.vcbacked.co/company/readily-diagnostics. Accessed July 20, 2026.
VCBacked. (2024). Readily Diagnostics — Funding & Investors. Retrieved July 20, 2026, from https://www.vcbacked.co/company/readily-diagnostics
{{cite web |title=Readily Diagnostics — Funding & Investors |url=https://www.vcbacked.co/company/readily-diagnostics |website=VCBacked |access-date=July 20, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated